Company Filing History:
Years Active: 2013-2019
Title: The Innovations of Liangyou Rui
Introduction
Liangyou Rui is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of therapeutic methods and small molecule inhibitors. With a total of 2 patents, his work focuses on addressing critical health issues through innovative solutions.
Latest Patents
Liangyou Rui's latest patents include the development of covalent small molecule DCN1 inhibitors and therapeutic methods using the same. These small molecule covalent inhibitors of DCN1 are designed to provide benefits in the treatment of various diseases and conditions, such as oxidative stress-related diseases, neurodegenerative diseases, metabolic disorders, and muscular nerve degeneration. Additionally, he has developed methods for administering lipocalins to treat metabolic disorders and cardiovascular diseases. This method involves administering a therapeutically effective amount of a lipocalin or a physiologically active fragment to patients in need.
Career Highlights
Liangyou Rui is affiliated with the University of Michigan, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating complex health conditions.
Collaborations
Some of his notable coworkers include Yingjiang Zhou and Shaomeng Wang, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Liangyou Rui's innovative work in developing therapeutic methods and small molecule inhibitors showcases his commitment to improving health outcomes. His contributions are paving the way for new treatments in various medical fields.